Compare BTG & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTG | IRTC |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | N/A | 2016 |
| Metric | BTG | IRTC |
|---|---|---|
| Price | $4.61 | $174.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | $6.00 | ★ $203.93 |
| AVG Volume (30 Days) | ★ 33.1M | 488.6K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $2,507,049,000.00 | $702,573,000.00 |
| Revenue This Year | $68.08 | $27.20 |
| Revenue Next Year | $22.77 | $16.89 |
| P/E Ratio | $28.94 | ★ N/A |
| Revenue Growth | ★ 30.97 | 25.45 |
| 52 Week Low | $2.20 | $81.87 |
| 52 Week High | $5.94 | $212.00 |
| Indicator | BTG | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 45.20 |
| Support Level | $4.35 | $171.24 |
| Resistance Level | $4.74 | $187.98 |
| Average True Range (ATR) | 0.19 | 6.61 |
| MACD | 0.07 | -0.60 |
| Stochastic Oscillator | 86.42 | 33.33 |
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.